The FDA ac­cused Chemo­Cen­tryx of ma­nip­u­lat­ing the re­sults of a piv­otal clin­i­cal tri­al used to ap­prove the drug Tavneos, es­ca­lat­ing the agen­cy's ef­fort to pull the treat­ment from the mar­ket...